Regeneron Antibody Drug Appears Effective Preventing COVID


US biotech firm Regeneron and its Swiss partner Roche unveiled promising clinical trial results on Monday indicating that an antibody treatment used to treat COVID-19 patients also helps prevent infections.


Check out the full story right here.

0 comments